(Q39308739)

English

Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

neoplastic stem cells

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cell differentiation

1 reference

based on heuristic

inferred from title

author name string

Yucui Dong

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Qinglian Han

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yan Zou

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Zhenling Deng

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Xinliang Lu

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Xiaohua Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Weihua Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hua Jin

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Jun Su

9

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Tao Jiang

10

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Huan Ren

11

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

25 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

370

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

89-102

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

https://scigraph.springernature.com/pub.10.1007/s11010-012-1401-0

0 references

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Glioma stem cells: a midterm exam.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Autocrine/paracrine platelet-derived growth factor regulates proliferation of neural progenitor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

KIT overexpression induces proliferation in astrocytes in an imatinib-responsive manner and associates with proliferation index in gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Platelet-derived growth factor receptors: a therapeutic target in solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Differentiation therapy exerts antitumor effects on stem-like glioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Mesenchymal differentiation of glioblastoma stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Human embryonic genes re-expressed in cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Oct4 is expressed in human gliomas and promotes colony formation in glioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Glioma formation, cancer stem cells, and akt signaling

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Long-term imatinib therapy promotes bone formation in CML patients

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1401-0

21 January 2018

Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-012-1401-0

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

release_ptyxd5rokzb4fcdigxe5etvoqq

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39308739&oldid=2048630128"